Loading
IV
IVX Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest was filed 11 May 2026.
IVX: what insiders have been doing
IVX has a thin disclosure history in our data (latest filing: 11 May 2026). New filings will appear here as soon as they are published. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAlistair Bennallack1 buy
Since the insiders bought
- -38.6%Entry A$0.06 · Close 15 Oct 2026 A$0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.04
Analyst consensus
Income statement
RevenueA$3.7M
Gross profitA$3.7M100% margin
EBITDA-A$3.3M-89% margin
Net income-A$8.8M-238.4% margin
Valuation
P/Book0.6x
Beta0.43
Balance sheet & cash
Market capA$3.9M
Free Cash Flow-A$3M
Debt / Equity29%
Profitability & ownership
ROE-83.0%
ROA-40.1%
% insiders46.7%
% institutions0.0%
Last declaration on 11 May 2026
Declarations1 total
12,963 sharesShareASXASX:2924-03088858-2A1671494
Canonical exit: 9 Aug 2026 (T+90)
1 of 1 declaration
About IVX
IVX is a company in the health and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
